Agresti C, Meomartini M E, Amadio S, Ambrosini E, Serafini B, Franchini L, Volonté C, Aloisi F, Visentin S
Department of Cell Biology and Neurosciences, Istituto Superiore di Sanità, Rome, Italy.
Glia. 2005 Apr 15;50(2):132-44. doi: 10.1002/glia.20160.
To gain insights into the role of purinergic receptors in oligodendrocyte development, we characterized the expression and functional activity of P2 receptors in cultured rat oligodendrocyte progenitors and investigated the effects of ATP and its breakdown products on the migration and proliferation of this immature glial cell population. Using Western blot analysis, we show that oligodendrocyte progenitors express several P2X (P2X(1,2,3,4,7)) and P2Y (P2Y(1,2,4)) receptors. Intracellular Ca(2+) recording by Fura-2 video imaging allowed to determine the rank potency order of the P2 agonists tested: ADPbetaS = ADP = Benzoyl ATP > ATP > ATPgammaS > UTP, alpha,beta-meATP ineffective. Based on the above findings, on pharmacological inhibition by the antagonists oxATP and MRS2179, and on the absence of alpha,betameATP-induced inward current in whole-cell recording, P2X(7) and P2Y(1) were identified as the main ionotropic and metabotropic P2 receptors active in OPs. As a functional correlate of these findings, we show that ATP and, among metabotropic agonists, ADP and the P2Y(1)-specific agonist ADPbetaS, but not UTP, induce oligodendrocyte progenitor migration. Moreover, ATP and ADP inhibited the proliferation of oligodendrocyte progenitors induced by platelet-derived growth factor, both in purified cultures and in cerebellar tissue slices. The effects of ATP and ADP on cell migration and proliferation were prevented by the P2Y(1) antagonist MRS2179. By confocal laser scanning microscopy, P2Y(1) receptors were localized in NG2-labeled oligodendrocyte progenitors in the developing rat brain. These data indicate that ATP and ADP may regulate oligodendrocyte progenitor functions by a mechanism that involves mainly activation of P2Y(1) receptors.
为深入了解嘌呤能受体在少突胶质细胞发育中的作用,我们对培养的大鼠少突胶质前体细胞中P2受体的表达及功能活性进行了表征,并研究了ATP及其分解产物对这种未成熟神经胶质细胞群体迁移和增殖的影响。通过蛋白质免疫印迹分析,我们发现少突胶质前体细胞表达多种P2X(P2X(1,2,3,4,7))和P2Y(P2Y(1,2,4))受体。利用Fura-2视频成像进行细胞内Ca(2+)记录,从而确定所测试的P2激动剂的效价顺序:ADPβS = ADP = 苯甲酰ATP > ATP > ATPγS > UTP,α,β-甲硫基ATP无效。基于上述发现、拮抗剂氧化ATP(oxATP)和MRS2179的药理学抑制作用以及在全细胞记录中不存在α,β-甲硫基ATP诱导的内向电流,确定P2X(7)和P2Y(1)是在少突胶质前体细胞中起作用的主要离子型和代谢型P2受体。作为这些发现的功能关联,我们发现ATP以及在代谢型激动剂中,ADP和P2Y(1)特异性激动剂ADPβS,但不是UTP,可诱导少突胶质前体细胞迁移。此外,ATP和ADP在纯化培养物和小脑组织切片中均抑制血小板衍生生长因子诱导的少突胶质前体细胞增殖。P2Y(1)拮抗剂MRS2179可阻断ATP和ADP对细胞迁移和增殖的影响。通过共聚焦激光扫描显微镜观察,P2Y(1)受体定位于发育中大鼠脑内NG2标记的少突胶质前体细胞中。这些数据表明,ATP和ADP可能通过主要涉及激活P2Y(1)受体的机制来调节少突胶质前体细胞的功能。